• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On August 3, according to US media Semafor, a Senate continuing resolution introduced by Senators Collins and Murray has been passed. The bill would provide government funding until December 11. The bill blocks a new rule that would allow the government to cancel funding to states such as blue states. Collins stated that the bill "prevents the Office of Management and Budget (OMB) from enacting its proposed rule regarding federal financial aid." Murray stated, "This bill blocks the implementation of this corrupt new OMB appropriations rule during the continuing resolutions validity period. This proposed rule would systematically politicize federal funding and allow Trump administration officials to cancel appropriations at any time for any reason."August 3 - The China Earthquake Networks Center officially measured a 3.3-magnitude earthquake at 03:29 on August 3 in Gao County, Yibin City, Sichuan Province (28.55 degrees north latitude, 104.67 degrees east longitude), with a focal depth of 5 kilometers.August 3rd - According to the Financial Times, British pharmaceutical giant AstraZeneca has been exploring a merger with its US rival Bristol-Myers Squibb, which would create one of the worlds largest pharmaceutical groups with a market capitalization of nearly $400 billion. Sources familiar with the matter revealed that the two companies have been in talks regarding the merger for several months, and negotiations may reach an agreement soon, but there is also a possibility of delays or a breakdown. AstraZeneca is the UKs second-largest listed company by market capitalization, at approximately £196 billion, while Bristol-Myers Squibb has a market capitalization of approximately $133 billion. If the deal is completed, it will be one of the largest corporate mergers and acquisitions in history. This transaction would further accelerate the British pharmaceutical giants strategic shift towards the US market.August 3rd - Sources familiar with the matter revealed that Italian company Prysmian is in advanced talks to acquire US electrical manufacturer Atkore. Prysmian is finalizing preparations for an all-cash acquisition, which could be announced in the coming days. Sources indicated that despite the advanced stage of negotiations, the deal could still be delayed or ultimately fall through. Atkores stock has risen approximately 15% this year in New York, with a market capitalization of around $2.5 billion. Prysmians stock has risen more than a third this year, with a market capitalization of approximately €36.3 billion (about $41.8 billion).The Saudi Arabian and Iranian foreign ministers spoke by phone to discuss diplomatic efforts to de-escalate tensions.

USD/CAD Price Analysis: Retracement Moves Seek Confirmation at 1,3000

Alina Haynes

May 13, 2022 10:00

USD/CAD consolidates recent advances while retreating from its highest level since November 2020, reaching a fresh intraday low around 1.3010 during the Asia session on Friday.

 

In doing so, the Loonie pair depicts a pullback from a four-day-old resistance line, which was near 1.3080 at the time of publication.

 

Given that the downward-sloping RSI (14) line is not oversold, the most recent price downturn may continue for a while longer before reaching any important support.

 

However, a junction of the 100-HMA and a one-week-old ascending trend line at 1.2995 is a formidable obstacle for USD/CAD bears.

 

In the event that the price falls below 1.2995, various levels surrounding 1.2920-10, including the high from early May and the 200-hour moving average, will attract pair sellers.

 

In contrast, a decisive breach of the aforementioned short-term resistance line of 1.3080 would require confirmation from the 1.3100 level before going for the peak of 1.3172 in late November 2020.

 

In conclusion, USD/CAD decline is not indicative of a trend reversal until the quotation breaks 1.2920.

The USD/CAD Hourly Graph

 image.png